HIGH SEVERITY

CVE-2019-6986

Vitro vulnerability

CVSS
7.5
EPSS
3.0%
EPSS pct
86th
Exploited
No known
SPARQL Injection in VIVO Vitro v1.10.0 allows a remote attacker to execute arbitrary SPARQL via the uri parameter, leading to a regular expression denial of service (ReDoS), as demonstrated by crafted use of FILTER%20regex in a /individual?uri= request.
Affected vendor
Duraspace
Affected product
Vitro
CVSS vector
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Weakness type (CWE)
  • CWE-77 — Command Injection
  • CWE-400 — Uncontrolled Resource Consumption
Published
2019-01-28

Risk analysis

Based on its CVSS vector, this vulnerability is exploitable over the network, low attack complexity, requiring no privileges, no user interaction. Successful exploitation leads to high impact to availability.

Its EPSS score of 3.0% reflects a lower probability of exploitation activity in the wild over the next 30 days, placing it above 86% of all scored CVEs.

Check your external exposure to CVE-2019-6986

  • Confirm whether Duraspace Vitro is running on any internet-facing host or subdomain.
  • Match discovered service fingerprints against the version affected by CVE-2019-6986.
  • Prioritise remediation if the asset is public, business-critical, or near authentication/payment flows.

How ThreatPort helps with CVE-2019-6986

ThreatPort's external attack surface scanner checks your internet-facing assets — agentlessly, from the outside in — for the exposed services and versions that CVE-2019-6986 affects, then prioritises the finding by real risk using CISA KEV and FIRST.org EPSS.

Run a free external exposure scan

Are you exposed to CVE-2019-6986?

Run an instant, non-intrusive external scan to check your attack surface for CVE-2019-6986.

Start free scan

No credit card. Agentless.